Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.
Freenome has raised $75.0M in total funding. The most recent round was Corporate Round. The last funding was announced in November 2025.
Freenome's investors include Andreessen Horowitz, RA Capital Management, Founders Fund, Sands Capital Ventures, Verily.
Freenome is headquartered in South San Francisco, United States.
Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.
Freenome is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Freenome — Funding & Investors." VCBacked, November 17, 2025, https://www.vcbacked.co/company/freenome. Accessed July 19, 2026.
VCBacked. (2025). Freenome — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/freenome
{{cite web |title=Freenome — Funding & Investors |url=https://www.vcbacked.co/company/freenome |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated